Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amisulpride Versus Olanzapine Treatment for Behavioral and Psychological Symptoms in Patients With Dementia of the Alzheimer Type:A Randomized, Open-label, Prospective Study

NCT04341467 is registered in ClinicalTrials.gov with Tianjin Anding Hospital as lead sponsor.

NCT NCT04341467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04341467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amisulpride Versus Olanzapine Treatment for Behavioral and Psychological Symptoms in Patients With Dementia of the Alzheimer Type:A Randomized, Open-label, Prospective Study
Lead sponsor
Tianjin Anding Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2019
Completion date
May 31, 2024
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amisulpride, bpsd, dementia of the alzheimer type, olanzapine